Dennis Bourdette

16.6k total citations
251 papers, 9.2k citations indexed

About

Dennis Bourdette is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Dennis Bourdette has authored 251 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Pathology and Forensic Medicine, 80 papers in Immunology and 43 papers in Neurology. Recurrent topics in Dennis Bourdette's work include Multiple Sclerosis Research Studies (111 papers), T-cell and B-cell Immunology (42 papers) and Immunotherapy and Immune Responses (41 papers). Dennis Bourdette is often cited by papers focused on Multiple Sclerosis Research Studies (111 papers), T-cell and B-cell Immunology (42 papers) and Immunotherapy and Immune Responses (41 papers). Dennis Bourdette collaborates with scholars based in United States, Slovakia and Canada. Dennis Bourdette's co-authors include Arthur A. Vandenbark, Ruth H. Whitham, Halina Offner, Michelle Cameron, Vijayshree Yadav, Gail Marracci, Rebecca Spain, Lynne Shinto, Michael Forte and Fay B. Horak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Dennis Bourdette

250 papers receiving 8.9k citations

Peers

Countries citing papers authored by Dennis Bourdette

Since Specialization

Citations

This map shows the geographic impact of Dennis Bourdette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Bourdette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Bourdette more than expected).

Fields of papers citing papers by Dennis Bourdette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Bourdette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Bourdette. The network helps show where Dennis Bourdette may publish in the future.

Co-authorship network of co-authors of Dennis Bourdette

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Bourdette. A scholar is included among the top collaborators of Dennis Bourdette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Bourdette. Dennis Bourdette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Industry Payments and Branded Glatiramer Acetate Prescribing in the US Medicare Program 2025 ·Neurology Clinical Practice ·Daniel M. Hartung, Sheila Markwardt, Dennis Bourdette	1
2	Characteristics of Prescription Drug Use Among Individuals With Multiple Sclerosis in the US Medicare Population 2022 ·International Journal of MS Care ·Daniel M. Hartung, Kirbee Johnston, Jessina C. McGregor, Dennis Bourdette	5
3	Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications 2021 ·Current Neurology and Neuroscience Reports ·Tyrell Simkins, Greg J. Duncan, Dennis Bourdette	40
4	Association Between Pharmacy Benefit Restrictions and Disease-Modifying Therapy Use in the Medicare Part D Program 2021 ·Neurology Clinical Practice ·Daniel M. Hartung, Kirbee Johnston, Jessina C. McGregor, Dennis Bourdette	2
5	The effect of out-of-pocket costs on initiation of disease-modifying therapies among medicare beneficiaries with multiple sclerosis 2020 ·Multiple Sclerosis and Related Disorders ·Daniel M. Hartung, Kirbee Johnston, Jessina C. McGregor, Dennis Bourdette	5
6	Closing the Part D Coverage Gap and Out-of-Pocket Costs for Multiple Sclerosis Drugs 2020 ·Neurology Clinical Practice ·Daniel M. Hartung, Kirbee Johnston, Dennis Bourdette, Randi Chen, Chien‐Wen Tseng	7
7	Cross-sectional survey of complementary and alternative medicine used in Oregon and Southwest Washington to treat multiple sclerosis: A 17-Year update 2020 ·Multiple Sclerosis and Related Disorders ·Elizabeth Silbermann, Angela Senders, (unknown), (unknown), Michelle Cameron, (unknown), (unknown), (unknown), Vijayshree Yadav, Dennis Bourdette, Rebecca Spain	14
8	Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial 2019 ·Multiple Sclerosis Journal - Experimental Translational and Clinical ·Julie Falardeau, (unknown), (unknown), Gail Marracci, Michele Mass, (unknown), Dennis Bourdette, Charles Murchison, William L. Hills, Vijayshree Yadav	10
9	Fear of Falling Is Associated with Recurrent Falls in People with Multiple Sclerosis 2015 ·International Journal of MS Care ·Rajarshi Mazumder, William E. Lambert, Thuan Nguyen, Dennis Bourdette, Michelle Cameron	58
10	Improving the Patient-Reported Outcome Experience for Participants and PI's: Feasibility and Validity of PROMIS 2014 ·The Journal of Alternative and Complementary Medicine ·Angela Senders, Douglas Hanes, Dennis Bourdette, Ruth H. Whitham, Lynne Shinto	1
11	Ginkgo biloba does not improve cognitive function in MS 2012 ·Neurology ·Jesús Lovera, Edward Kim, (unknown), Mary Anne Fitzpatrick, (unknown), Aaron P. Turner, (unknown), (unknown), (unknown), Alicia P. Sloan, Diane Howieson, Katherine Wild, Jodie K. Haselkorn, Dennis Bourdette	40
12	A Randomized Pilot Study of Naturopathic Medicine in Multiple Sclerosis 2008 ·The Journal of Alternative and Complementary Medicine ·Lynne Shinto, Carlo Calabrese, Cynthia D. Morris, Vijayshree Yadav, (unknown), Rachel M. Frank, Barry Oken, (unknown), Dennis Bourdette	25
13	Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis 2007 ·Proceedings of the National Academy of Sciences ·Michael Forte, Bruce G. Gold, Gail Marracci, Priya Chaudhary, Emy Basso, (unknown), Xiaolin Yu, (unknown), (unknown), (unknown), Paolo Bernardi, Dennis Bourdette	182
14	Frequency-Modulation (FM) Technology as a Method for Improving Speech Perception in Noise for Individuals with Multiple Sclerosis 2006 ·Journal of the American Academy of Audiology ·(unknown), (unknown), David J. Lilly, Dennis Bourdette, Julie Saunders, Stephen A. Fausti	15
15	Complementary and Alternative Medicine in Multiple Sclerosis: Survey of Licensed Naturopaths 2004 ·The Journal of Alternative and Complementary Medicine ·Lynne Shinto, Carlo Calabrese, Cynthia D. Morris, (unknown), Dennis Bourdette	22
16	Monomeric Recombinant TCR Ligand Reduces Relapse Rate and Severity of Experimental Autoimmune Encephalomyelitis in SJL/J Mice through Cytokine Switch 2004 ·The Journal of Immunology ·Jianya Huan, Sandhya Subramanian, Richard E. Jones, Cathleen Rich, Jason M. Link, (unknown), Dennis Bourdette, Arthur A. Vandenbark, Gregory G. Burrows, Halina Offner	46
17	Epitope Spreading Is Not Required for Relapses in Experimental Autoimmune Encephalomyelitis 2003 ·The Journal of Immunology ·Richard E. Jones, Dennis Bourdette, (unknown), Arthur A. Vandenbark, Alex Zamora, Halina Offner	21
18	Therapeutic application of T cell receptor peptides 1997 ·Drug News & Perspectives ·Arthur A. Vandenbark, Y. K. Chou, Dennis Bourdette, Ruth H. Whitham, Halina Offner	7
19	TCR peptide vaccination induced TH2 immune regulation in multiple sclerosis 1996 ·The FASEB Journal ·Arthur A. Vandenbark, Y. K. Chou, Ruth H. Whitham, Abigail C. Buenafe, (unknown), D. Cavanagh, Stewart Cooper, George A. Hashim, Halina Offner, Dennis Bourdette	1
20	Human myelin basic protein (MBP) epitopes recognized by mouse MBP-selected T cell lines from multiple sclerosis patients 1994 ·Journal of Neuroimmunology ·Yuan K. Chou, Richard E. Jones, Dennis Bourdette, (unknown), George A. Hashim, (unknown), Halina Offner, Arthur A. Vandenbark	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact